The CAMTA1 gene product has been demonstrated to play an integral role in the regulation of microRNA profiles (i.e., miR-212/miR-132) and beta cell function, with the differential expression of transcript levels implicated in the pathogenesis of diabetes (Mollet et al., 2016). This evidence concerns the gene CAMTA1 and diabetes mellitus.